Kailera Therapeutics is a clinical-stage biotechnology company that provides revolutionary therapies for treating obesity and related diseases. Kailera Therapeutics is advancing a range of injectable and oral GLP-1 (Glucagon-like peptide-1) therapies for obesity and related diseases.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.